SOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation.

Organized by the Japanese External Trade Association, the Chiba Healthcare Business Forum attracts the most advanced academic and research institutions as well as healthcare and life science companies worldwide to present their latest research projects and business developments.

Maria Zimina, Business Development Manager of SOM Biotech highlights: “The Chiba Healthcare Business Forum is a unique event for companies of the life science and healthcare sectors. We look forward to presenting the advantages and effectiveness of our proprietary AI-based drug discovery platform and to exploring partnerships with innovative pharmaceutical companies and research institutions. The high efficacy and versatility of our pioneering technology have allowed SOM Biotech not only to build a robust drug development pipeline but also to become a fundamental ally for those pharmaceutical companies that want to rescue and reposition their own drugs to increase their lifecycle and generate additional value.

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

La dieta Mediterránea ayuda a mejorar l...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Las mejoras en memoria son proporcionales al incremento en la adherenc...

Diapositiva de Fotos